Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Interleukin-23 Receptor Peptide Inhibitors Compositions 2023-5-31 2023-6-20
Conjugated hepcidin mimetics 2023-2-02 2023-8-10
Conjugated hepcidin mimetics 2023-2-02 2023-8-10
Peptide inhibitors of interleukin-23 receptor and use thereof for treating … 2022-12-02 2023-1-26
INTERLEUKIN-23 RECEPTOR PEPTIDE INHIBITORS AND THEIR USE TO TREAT INFLAMMATORY … 2022-8-11 2022-9-30
Bicyclic peptide inhibitors of interleukin-23 receptor 2022-7-14 2023-1-19
Peptide inhibitors of interleukin-23 receptor 2022-7-14 2023-2-23
Lipidated peptide inhibitors of interleukin-23 receptor 2022-7-14 2023-3-02
Methods for treating inflammatory bowel diseases with α4β7 integrin antagonists 2022-7-07 2022-9-01
Hepcidin mimetics for treatment of hereditary hemochromatosis 2022-6-14 2023-5-01
Conjugated hepcidin mimetics 2022-4-01 2023-2-01
Conjugated hepcidin mimetics 2022-4-01 2023-2-01
CONJUGATED HEPCIDIN MIMETIC 2022-3-31 2023-6-28
CONJUGATED HEPCIDIN MIMETIC 2022-3-31 2023-6-28
Conjugated hepcidin mimetics 2022-3-31 2022-10-06
Conjugated hepcidin mimetics 2022-3-01 2022-5-01
Peptide inhibitors of interleukin-23 receptor and their use to treat … 2022-1-04 2022-3-01
Peptide inhibitors of interleukin-23 receptor and their use to treat … 2021-12-13 2022-8-11
Compositions of peptide inhibitors of interleukin-23 receptor 2021-11-19 2023-8-29
α4β7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS 2021-11-01 2022-1-14
Oral peptide inhibitors of interleukin-23 receptor and their use to treat … 2021-8-15 2021-9-30
Conjugated hepcidin mimetics 2021-7-28 2023-2-09
NOVEL a4B7 PEPTIDE MONOMER AND DIMER ANTAGONISTS 2021-7-16 2022-5-26
Interleukin 23 Receptor Peptide Inhibitors (Divisional Application No. … 2021-2-09 2021-8-06
Peptide inhibitors of interleukin-23 receptor and their use to treat … 2021-1-14 2022-11-23
Peptide inhibitors of interleukin-23 receptor and their use to treat … 2021-1-14 2021-7-22
Hepcidin analogues and uses thereof 2020-11-16 2022-11-03
Analogues of hepcidin mimetics with improved in vivo half lives 2020-10-01 2022-10-18 2022-10-18
INTERLEUKIN-23 RECEPTOR PEPTIDE INHIBITORS AND THEIR USE TO TREAT INFLAMMATORY … 2020-7-13 2021-12-15
Methods for synthesizing β-homoamino acids 2020-3-27 2021-11-18
PEPTIDIC INHIBITORS OF THE INTERLEUQUIN-23 RECEPTOR AND THEIR USE IN THE … 2019-7-12 2020-9-16
Hepcidin and mini-hepcidin analogues and uses therof 2019-6-12 2020-1-16
Opioid agonist peptides and uses thereof 2019-3-06 2019-8-01
NOVEL a4ß7 PEPTIDE DIMER ANTAGONISTS 2019-2-22 2019-8-15
NOVEL a4B7 PEPTIDE ANTAGONISTS 2019-2-22 2020-1-16
Conjugated hepcidin mimetics 2019-2-08 2022-4-06
Novel alpha4beta7 peptide dimer antagonists 2018-8-27 2018-9-13
Methods for determining and monitoring gastrointestinal inflammation 2017-11-09 2018-5-17
Peptide inhibitors of interleukin-23 and their use to treat inflammatory … 2017-7-27 2019-9-05
Disulfide-rich peptide libraries and methods of use thereof 2017-7-27 2018-2-01
Methods for synthesizing α4β7 peptide antagonists 2017-3-23 2019-9-10 2019-9-10
Peptide inhibitors of interleukin-23 receptor and their use to treat … 2016-7-15 2020-9-29 2020-9-29
Novel cyclic monomer and dimer peptides having integrin antagonist activity 2015-10-01 2018-4-19
Hepcidin analogues and uses therof 2014-3-17 2021-11-30